Cargando…
Gamma Secretase Inhibitors as Potential Therapeutic Targets for Notch Signaling in Uterine Leiomyosarcoma
Uterine leiomyosarcoma (uLMS) is a rare and aggressive cancer with few effective therapeutics. The Notch signaling pathway is evolutionarily conserved with oncogenic properties, but it has not been well studied in uLMS. The purpose of our study was to determine expression of Notch family genes and p...
Autores principales: | Abedin, Yasmin, Gabrilovich, Sofia, Alpert, Emily, Rego, Erica, Begum, Salma, Zhao, Qingshi, Heller, Debra, Einstein, Mark H., Douglas, Nataki C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180633/ https://www.ncbi.nlm.nih.gov/pubmed/35682660 http://dx.doi.org/10.3390/ijms23115980 |
Ejemplares similares
-
Gamma secretase inhibitors of Notch signaling
por: Olsauskas-Kuprys, Roma, et al.
Publicado: (2013) -
Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2016) -
Uterine Leiomyosarcoma
por: Byar, Katherine L., et al.
Publicado: (2022) -
NOTCH2 gene mutation and gamma-secretase inhibitor in mediating the malignancy of ovarian cancer
por: Wang, Wenjing, et al.
Publicado: (2023) -
Adipocyte-specific blockade of gamma-secretase, but not inhibition of Notch activity, reduces adipose insulin sensitivity
por: Sparling, David P., et al.
Publicado: (2015)